News & Events
In The News
3 Takeaways From The Lex Machina PTAB Report
Above The Law, August 11, 2020
It is hard not to read the Lex Machina report without at least a measure of respect for the PTAB’s ability to keep to the statutory deadlines for cases that were already pending when COVID-19 hit.
New Survey Shows COVID-19’s Effect on Petitions Filed at USPTO
WIPR, August 7, 2020
Patent petitions and disputes filed at the US Patent and Trademark Office (USPTO) increased earlier this year, soaring by 76% and 114% respectively in February, before falling the following month, a new survey tracking the effects of COVID-19 on the US legal system reveals.
Intel is a Major Patent Force and That Matters
IAM, August 7, 2020
Intel has a global portfolio of 65,932 active patents, 42,710 of which are grants and 23,222 applications. The company’s filing output increased significantly after 2010 and hit its peak in 2015 and 2016.
Upcoming Events
There are no events scheduled at this time.
Press Releases
July 30, 2020
Lex Machina Brings Unprecedented Coverage to Legal Analytics
Lex Machina, a LexisNexis company, today announced its expanded federal district court coverage, which gives users access to all commercially relevant federal civil cases in one place. Users can now find any federal district court case and use it as a jumping off point to discover key analytics including information about judges, law firms, attorneys, or parties.
July 9, 2020
Lex Machina Develops New Torts Module for Legal Analytics
Lex Machina announced the expansion of its award-winning Legal Analytics platform with its new Torts module covering nearly 200,000 cases pending in federal district court since 2009. The Torts practice area includes cases in which a party seeks compensation for loss or harm caused by personal injury or reputational harm to an individual.
June 16, 2020
Lex Machina Launches the New Public-facing COVID-19 Impact Analyzer App to Track the Impacts of COVID-19 on Federal Litigation
Lex Machina announced a significant new addition to its product: The COVID-19 Impact Analyzer App (the “COVID App”). The COVID App provides data and analytics to understand the impact that COVID-19 has had and continues to have on federal district court litigation.